Cargando…

Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients

High-dose chemotherapy (HD-Cx) in refractory germ cell cancer (GCC) is effective but limited data are available concerning the optimal approach for stem cell mobilization (SCM) in these patients. In this analysis 102 patients undergoing SCM during first (n = 25) or subsequent treatment lines (n = 77...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madanchi, Ramin, Engel, Nils W., Alsdorf, Winfried, Oing, Christoph, Frenzel, Christian, Paulsen, Finn-Ole, Bokemeyer, Carsten, Seidel, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090625/ https://www.ncbi.nlm.nih.gov/pubmed/35190673 http://dx.doi.org/10.1038/s41409-022-01614-9

Ejemplares similares

Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors
por: Kirchner, Kira, et al.
Publicado: (2023)

5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
por: Oing, Christoph, et al.
Publicado: (2018)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment
por: Alsdorf, Winfried H., et al.
Publicado: (2020)

Erweiterung der Kombinationsmöglichkeiten in der Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms mit Nivolumab plus Cabozantinib: Ergebnisse der CheckMate-9ER-Studie
por: Oing, Christoph, et al.
Publicado: (2021)

Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)
por: Seidel, Christoph, et al.
Publicado: (2022)

The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells
por: Dyshlovoy, Sergey A., et al.
Publicado: (2017)

Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
por: Tran, Ben, et al.
Publicado: (2019)

First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group
por: Pfister, David, et al.
Publicado: (2022)

Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
por: Karagiannis, Panagiotis, et al.
Publicado: (2020)

Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines
por: Bremmer, Felix, et al.
Publicado: (2019)

Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
por: Majewski, Matthäus, et al.
Publicado: (2023)

Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia
por: Engel, Nils W., et al.
Publicado: (2019)

The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
por: Seidel, Christoph, et al.
Publicado: (2021)

Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
por: Port, Matthias, et al.
Publicado: (2011)

Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review
por: Kaufmann, Ernest, et al.
Publicado: (2022)

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?
por: von Amsberg, Gunhild, et al.
Publicado: (2022)

Surgical treatment of metastatic germ cell cancer
por: Hiester, Andreas, et al.
Publicado: (2021)

ESMO20 YO for YO: highlights on metastatic renal cell carcinoma—the CheckMate-9ER trial
por: Kfoury, M., et al.
Publicado: (2021)

Improved outcomes in metastatic germ cell cancer: results from a large cohort study
por: Hentrich, Marcus, et al.
Publicado: (2020)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
por: Gillessen, Silke, et al.
Publicado: (2021)

Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review
por: Ruf, Christian G., et al.
Publicado: (2022)

Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
por: Kollmannsberger, C, et al.
Publicado: (2003)

The component of the m(6)A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2021)

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
por: Koch, S, et al.
Publicado: (2003)

Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours
por: Ohlmann, Carsten-Henning, et al.
Publicado: (2021)

Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)
por: Seidel, C, et al.
Publicado: (2013)

How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence
por: Winter, Christian, et al.
Publicado: (2022)

Hodentumoren aus klinischer Sicht: Was Urolog:Innen und Onkolog:Innen von Patholog:Innen über Hodentumoren wissen müssen
por: Oing, Christoph, et al.
Publicado: (2022)

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2022)

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.
por: Mason, M. D., et al.
Publicado: (1991)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992)

CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
por: Oz Atalay, Fatma, et al.
Publicado: (2016)

Low Survival in Poor Prognosis Metastatic Germ Cell Cancer in Belarus
por: Rolevich, Alexander I., et al.
Publicado: (2021)

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
por: Ghandili, Susanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l3bb96ru1uhma29hbkrja4u3g6